Nothdurft et al. (65) determined that AHR depletion by shRNA augments invasiveness in vitro and metastatic capability of non-small cell lung cancer cells in vivo via regulation of the EMT pathway, ATF4 signaling, and MMP24 expression. The gene discussed is AHR; the disease is non-small cell lung carcinoma.